Lefloxacin 250 mg Tablets (Levofloxacin Hemihydrate)

Adult dose

For typical adult levofloxacin, orally administer 250-750 mg once daily. 1. Patients with normal renal function (creatinine clearance greater than 80 mL/min) - Complicated skin and soft tissue infections: 750 mg every 24 hours for 10-14 days. - Community-acquired pneumonia: 500 mg every 24 hours for 7 days. - Acute bacterial exacerbation of chronic bronchitis: 7 days. - Acute sinusitis: 10-14 days. -

This medication belongs to the fluoroquinolone class of antibiotics, used to treat specific bacterial infections. Serious adverse reactions such as tendonitis or tendon rupture, peripheral neuropathy may occur during the course of this medication, and it is essential to discontinue use immediately if such symptoms appear. This medication should not be used in patients with myasthenia gravis, as it may worsen symptoms. Use is limited to acute bacterial sinusitis, acute exacerbation of chronic bronchitis, uncomplicated urinary tract infections, and acute otitis media. Extra caution should be exercised in elderly patients, patients with impaired renal function, solid organ transplant recipients, and those taking corticosteroids, as the risk of tendon rupture may increase. Pregnant women, those who may become pregnant, nursing mothers, and adolescents under 18 years should not use this medication. It may affect the central nervous system and increase the risk of seizures, so caution is warranted in patients with a history of epilepsy or brain disorders. Patients should avoid excessive sun exposure during treatment, and if phototoxic reactions occur, administration should be discontinued immediately. Symptoms such as dizziness or drowsiness may occur, necessitating caution when driving or operating machinery. Various side effects, including gastrointestinal disturbances, liver function abnormalities, hematological abnormalities, cardiac rhythm disturbances, and skin rashes may occur, and medical consultation should be sought if abnormal symptoms develop. Additionally, this drug may interact with other medications, so it is vital to inform healthcare providers of any other medications being taken. Overdose may lead to central nervous system symptoms and cardiac problems, requiring prompt treatment and monitoring. The safety of this drug in growing children and adolescents has not been established, and it should not be used in this population. Therefore, it is crucial to follow the physician's instructions when using this medication, and to consult a healthcare provider immediately if any side effects or abnormal symptoms arise.

Serious side effects

Urticaria, severe swelling, chest tightness, difficulty breathing, cold sweat, pallor, shock, anaphylactic reaction, hypotensive shock, seizure, loss of consciousness, tingling sensation, vascular edema, airway obstruction, respiratory distress, severe allergic reactions, and severe cutaneous adverse reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis, DRESS), hepatic abnormalities (including acute liver necrosis, acute liver failure, severe hepatitis, liver dysfunction, jaundice), and serious neurological effects.

Mild side effects

Nausea, diarrhea, vaginitis, insomnia, abdominal pain, bloating, itchiness, dizziness, rash, indigestion, stomatitis, glossitis, dry mouth, constipation, vomiting, fungal infections, genital itching, headache, neurosis, erythematous rash, decreased appetite, drowsiness, excitement, thirst, tremors, allergic reactions, palpitations, QT interval prolongation on electrocardiogram, arrhythmias, elevated BUN, increased serum creatinine, leukopenia, anemia, decreased hemoglobin

This medication should be stored in a tightly closed container to protect it from air and moisture, at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the efficacy of the medication safely.

Appearance

Light pink rectangular film-coated tablet

Package unit

30 Tablets/Bottle, 100 Tablets/Bottle